News and Reports
-
FORE Biotherapeutics Announces Positive Outcome from First Planned Interim Efficacy Analysis from FORTE Basket Study Evaluating Plixorafenib Monotherapy in Advanced Solid Tumors with BRAF Fusions
1 September 2026Download -
Fangzhou Reports Sustained Revenue and Profit Growth as AI-Powered Chronic Care Strategy Gains Momentum
27 August 2026Download -
Mahzi Therapeutics Announces FDA Rare Pediatric Disease Designation for MZ-1866 Investigational Therapy for Pitt Hopkins Syndrome
25 August 2026Download -
Crystalys Therapeutics Announces $130 Million Series B Financing to Advance Global Phase 3 Development and Commercialization of Dotinurad for Gout
22 July 2026Download -
Fangzhou Launches Novo Nordisk’s Once-Weekly Basal Insulin/GLP-1 Therapy in China
20 July 2026Download -
Shape Memory Medical Completes Enrollment in Landmark AAA-SHAPE Randomized Controlled Pivotal Trial
8 July 2026Download -
FORE Biotherapeutics Announces Closing of Upsized $67.4 Million Series D-2 Extension Financing and Highlights Recent Plixorafenib Achievements
6 July 2026Download -
Lycia Therapeutics Raises $75 Million in Oversubscribed Financing and Strengthens Leadership Team with Appointment of Chief Financial Officer and General Counsel
25 June 2026Download -
Corxel Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Trial of CX11 in Obese and Overweight U.S. Adults
23 June 2026Download -
Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
11 June 2026Download -
Swixx completes strategic investment from SK Capital and Bain Capital Life Sciences to support continued gobal expansion
1 June 2026Download -
Curevo to be Acquired by Lilly to Advance Next-Generation Shingles Prevention
26 May 2026 -
Vincentage Pharma Reports Positive Top-Line Results from Pivotal Phase 3 Trial of VCT220 in Obese or Overweight Chinese Adults
18 May 2026Download -
Parabilis Medicines Announces Strategic Collaboration with Regeneron Pharmaceuticals to Advance Novel Antibody-Helicon™ Conjugates Across Multiple Therapeutic Areas
18 May 2026Download -
Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering
7 May 2026Download -
CellCentric Announces Oversubscribed $220m Series D Financing to Advance Pivotal Trials of Inobrodib in Multiple Myeloma
6 May 2026Download -
SnapCare and connectRN Join Forces to Provide Growth- Forward Workforce Solutions Powering Better Care
29 April 2026Download -
SWIXX Enters Into a Strategic Multiregional Distribution Partnership with BRIDGEBIO
30 March 2026Download -
Fangzhou Reports Robust 2025 Financial Results, Boosted by AI Chronic Care Strategy
19 March 2026Download -
Nuance Pharma Announces Approval of Ohtuvayre® (ensifentrine) in Hong Kong SAR, China
12 March 2026Download -
SWIXX BIOPHARMA EXPANDS PARTNERSHIP WITH ELI LILLY TO BRAZIL
4 March 2026Download -
ADARx Pharmaceuticals Presents Onvuzosiran Data Supporting Potential for Sustained Attack-Free Rates with Reduced Treatment Burden in Patients with HAE
27 February 2026Download -
SWIXX AND MADRIGAL ANNOUNCE EXCLUSIVE EUROPEAN PARTNERSHIP ON FIRST TARGETED THERAPY FOR MASH
3 February 2026Download -
Fangzhou Issues Positive Profit Forecast as AI-Driven Chronic Care Model Delivers First Full-Year Profit
26 January 2026Download -
CORXEL Announces $287 million Series D1 Financing to Further Advance Its Cardiometabolic Pipeline including Oral Small Molecule GLP-1 Receptor Agonist
22 January 2026Download